Ambu AS (AMBU B):企業の財務・戦略的SWOT分析

◆英語タイトル:Ambu AS (AMBU B) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME983FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Ambu AS (AMBU B) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Ambu A/S (Ambu) is a medical device company that manufactures and markets life supporting devices. It focuses on single-use devices for anesthesia, patient monitoring and diagnostics and emergency care. It serves hospitals, clinics, sleep laboratories and rescue services. The company’s product portfolio includes ventilation products for artificial respiration, resuscitators, single-use videoscopes, electrodes for ECG tests and neurophysiological tests, and manikins for first aid training. Ambu sells its medical devices through direct sales force and a network of distributors to hospitals and ambulances worldwide and operates offices in North America, Europe and Asia-Pacific. It has production facilities in China, Malaysia and the US. Ambu is headquartered in Ballerup, Denmark.

Ambu AS Key Recent Developments

Nov 13,2020: Candidate for new chairman of Ambu
Nov 11,2020: Ambu: Annual report 2019/20 (Earnings release)
Aug 26,2020: Ambu: Interim report for Q3 2019/20
Apr 15,2020: Researchers warn that contaminated reusable bronchoscopes could cause secondary infections and higher mortality rates in COVID-19 Patients, Ambu Reports
Apr 06,2020: Ambu reports revenue growth for Q2 and raises the revenue guidance for the year

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Ambu A/S – Key Facts
Ambu A/S – Key Employees
Ambu A/S – Key Employee Biographies
Ambu A/S – Major Products and Services
Ambu A/S – History
Ambu A/S – Company Statement
Ambu A/S – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Ambu A/S – Business Description
Business Segment: Anaesthesia
Overview
Performance
Business Segment: Patient Monitoring & Diagnostics
Overview
Performance
Business Segment: Visualization
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: North America
Performance
Geographical Segment: Rest of the world
Performance
Ambu A/S – Corporate Strategy
Ambu A/S – SWOT Analysis
SWOT Analysis – Overview
Ambu A/S – Strengths
Ambu A/S – Weaknesses
Ambu A/S – Opportunities
Ambu A/S – Threats
Ambu A/S – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Ambu A/S, Medical Equipment, Deals By Year, 2015 to YTD 2021
Ambu A/S, Medical Equipment, Deals By Type, 2015 to YTD 2021
Ambu A/S, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 13, 2020: Candidate for new chairman of Ambu
Nov 11, 2020: Ambu: Annual report 2019/20 (Earnings release)
Aug 26, 2020: Ambu: Interim report for Q3 2019/20
Apr 15, 2020: Researchers warn that contaminated reusable bronchoscopes could cause secondary infections and higher mortality rates in COVID-19 Patients, Ambu Reports
Apr 06, 2020: Ambu reports revenue growth for Q2 and raises the revenue guidance for the year
Mar 18, 2020: Ambu’s production exempt from Malaysian movement control order
Mar 17, 2020: Ambu : Malaysian government orders two-week movement control
Feb 04, 2020: Ambu A/S: Interim report for Q1 2019/20
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Ambu A/S, Key Facts
Ambu A/S, Key Employees
Ambu A/S, Key Employee Biographies
Ambu A/S, Major Products and Services
Ambu A/S, History
Ambu A/S, Subsidiaries
Ambu A/S, Key Competitors
Ambu A/S, Ratios based on current share price
Ambu A/S, Annual Ratios
Ambu A/S, Annual Ratios (Cont...1)
Ambu A/S, Annual Ratios (Cont...2)
Ambu A/S, Interim Ratios
Ambu A/S, Medical Equipment, Deals By Year, 2015 to YTD 2021
Ambu A/S, Medical Equipment, Deals By Type, 2015 to YTD 2021
Ambu A/S, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Ambu AS (AMBU B):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hertel Holding BV:企業の戦略的SWOT分析
    Hertel Holding BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • EP Energy Corp (EPE):石油・ガス:M&Aディール及び事業提携情報
    Summary EP Energy Corp (EP Energy) is an oil and gas exploration and production company that offers acquisition and development of unconventional onshore oil and natural gas properties in the US. The company operates Altamont program, Eagle Ford program and Wolfcamp program. Its Eagle Ford program i …
  • Ssr Mining Inc
    Ssr Mining Inc - Strategy, SWOT and Corporate Finance Report Summary Ssr Mining Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • U.S. Venture Inc:企業の戦略的SWOT分析
    U.S. Venture Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Chiome Bioscience Inc (4583):製薬・医療:M&Aディール及び事業提携情報
    Summary Chiome Bioscience Inc (Chiome Bioscience) is a healthcare service company that provides research and development of therapies. The company research and develops antibody drugs for the treatment of autoimmune and inflammatory diseases. Its ADLib system is a monoclonal antibody generating syst …
  • GlaxoSmithKline Plc (GSK)-製薬・医療分野:企業M&A・提携分析
    Summary GlaxoSmithKline Plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of respiratory, cancer, cardiovascular, HIV and infectious diseases, respira …
  • NEC Networks & System Integration Corp (1973):企業の財務・戦略的SWOT分析
    NEC Networks & System Integration Corp (1973) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • H.B. Fuller Co (FUL):企業の財務・戦略的SWOT分析
    H.B. Fuller Co (FUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Scapa Group plc (SCPA):企業の財務・戦略的SWOT分析
    Scapa Group plc (SCPA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Kelda Group Ltd:企業の戦略・SWOT・財務情報
    Kelda Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Kelda Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • The Ultimate Software Group Inc:企業の戦略的SWOT分析
    The Ultimate Software Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Exicure Inc (XCUR):製薬・医療:M&Aディール及び事業提携情報
    Summary Exicure Inc (Exicure), formerly AuraSense Therapeutics LLC is a biotechnology company that discovers, develops, and commercializes immunomodulatory and gene silencing drugs based on 3-dimensional spherical nucleic acid constructs. The company’s technology portfolio includes SNA gene regulati …
  • Kellogg Co:企業の戦略・SWOT・財務情報
    Kellogg Co - Strategy, SWOT and Corporate Finance Report Summary Kellogg Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • A.P. Moller – Maersk AS Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    A.P. Moller - Maersk AS Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary A.P. Moller - Maersk AS (APM) is an integrated transport and logistics company with operations in container shipping and ports operating through a subsidiary and affiliates. It transports dry …
  • Chubu Electric Power Co Inc (9502):石油・ガス:M&Aディール及び事業提携情報
    Summary Chubu Electric Power Co Inc (Chubu) is an energy utility. It generates and procures electricity; and offers electric network related services. The company produces electricity using hydro, thermal, nuclear and renewable sources. Chubu has interests in upstream and midstream energy fields. It …
  • Scienion AG:医療機器:M&Aディール及び事業提携情報
    Summary Scienion AG (Scienion) is a life science company that offers solutions for liquid dispensing applications. The company’s products include scireader cl, innoscan microarray scanners, sciflexarrayer, sciliner lateral flow dispenser, sciconsumables- sciplexplates 96, scichip, scibuffer, scihybc …
  • Myriad RBM Inc-医療機器分野:企業M&A・提携分析
    Summary Myriad RBM Inc (Myriad RBM), formerly Rules Based Medicine Inc, a subsidiary of Myriad Genetics Inc, is an immunoassay testing laboratory that provides protein biomarker products and services. The company’s products and services include HumanMAP services that assist investigators in the disc …
  • National Thermal Power Corporation Ltd:企業の戦略・SWOT・財務分析
    National Thermal Power Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary National Thermal Power Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Daimler AG (DAI):電力:M&Aディール及び事業提携情報
    Summary Daimler AG (Daimler) is an automobile company that undertakes the manufacture, distribution and sales of premium passenger cars, commercial vehicles and related spare part and accessories. The company also provides services such as financing, leasing, fleet management, insurance, financial i …
  • Illinois Tool Works Inc.:企業の戦略・SWOT・財務情報
    Illinois Tool Works Inc. - Strategy, SWOT and Corporate Finance Report Summary Illinois Tool Works Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆